3/7/2025Innovent Launches Phase 2 Trial of IBI362 for Heart Failure Patients w...

3/7/2025Recent Executive Moves

3/6/2025Bayer Expands Innovation in China with New E-Town Center

3/6/2025Nhwa Pharma Acquires Stake in Neuro3 to Expand CNS Drug Pipeline  

3/6/2025AI, Biomanufacturing, and Six Takeaways from China’s Government Work ...

3/5/2025CStone Announces First Patient Dosed in Global Trial of Trispecific An...

3/5/2025China to Adjust Centralized Drug Procurement Policies

3/4/2025Raziel and Fosun's JuveStar Launch Phase 3 Trial in China for RZL-012

3/4/2025Amoytop's Strategic Acquisition of Skyline Assets Marks Expansion into...

3/4/2025Insilico and Tenacia Announce Research Collaboration for CNS Drug Disc...

3/4/2025HighTide Thera Publishes Positive Phase 2 Data on HTD1801 for Type 2 D...

3/4/2025BeiGene's TEVIMBRA Approved in U.S. for First-line Treatment of Advanc...

3/4/2025The United Labs' UBT251 Injection Receives FDA Approval for Phase II C...

3/4/2025Longbio Pharma's LP-003 Shows Promising Results in Phase II CSU Trial

3/4/2025Bioray's BR111: Pioneering Dual-Epitope ADC for ROR1-Positive Cancers

3/4/2025Hansoh Pharma's HS-20089 Advances to Phase III Trial for Platinum-Resi...

3/4/2025Trump's 'America First' Investment Policy Raises Uncertainty for US-Ch...

3/3/2025Innovent's IBI363 Enters Pivotal Trial, Challenging Keytruda in Melano...

2/28/2025Duality Biologics Withdraws Hong Kong IPO Plans Amidst Strategic Partn...

2/28/2025NMPA Approves Multiple Drugs for Cancer, Cardiovascular, and Liver Dis...

2/28/2025CDE Seeks Public Feedback on "SPARK Initiative" to Boost Pediatric Onc...

2/28/2025Recent Executive Moves

2/28/2025Henlius Initiates Phase 1b/2 Trial for PD-L1 ADC HLX43 in Solid Tumors

2/28/2025SciClone Secures Rights to Eisai's Tasurgratinib for Greater China

2/28/2025China's Tech Giants Look to Healthcare (The Wire China)

2/28/2025Pace, Price of China Licensing Deals Continues to Rise (BioCentury)

2/27/2025Fail to Launch: Affordable Gene Therapy from China - A Realty Within R...

2/27/2025IVIEW Thera Reports Positive Phase 1/2 Results for IVW-1001 Ophthalmic...

2/27/2025HBM Alpha Enters License Deal to Advance Novel Endocrine Therapies

2/27/2025Henlius Registers Phase 3 Trials for Keytruda and Yervoy Biosimilars

Page:8/761 Total number of articles:22823: [First][<<] [6] [7] [8] [9] [10] [>>] [End]